Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Neurocrine Biosciences
Biotech
Neurocrine blows fresh wind in Voyager's sails with $175M payday
Voyager’s bet on its capsid technology continues to pay off as the company banks $175 million from a renewed collaboration with Neurocrine.
James Waldron
Jan 9, 2023 9:30am
Neurocrine's $45M bet goes 0 for 2 with rare epilepsy flop
Dec 7, 2022 7:20am
Neurocrine axes essential tremor program on phase 2 data
Aug 5, 2022 4:53am
Neurocrine pens $2.6B biobucks pact with Sosei Heptares
Nov 22, 2021 9:15am
Takeda's CNS deep dive with PeptiDream could net $3.5B
Jul 28, 2021 10:41am
Neurocrine exits $165M Parkinson's pact with Voyager
Feb 3, 2021 10:01am
